Healthcare

ISEC Healthcare’s net profit dips 6% to $3.18m in Q1

ISEC Healthcare’s net profit dips 6% to $3.18m in Q1

Administrative expenses grew due to increased business activities under specialised health services.

Cordlife directors seek court block on share issue

The company earlier announced the issuance of 51.2 million shares via private placement. 

SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement

The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.

Cordlife Group aims to raise $8.04m in private placement

It issued 51.2 million new shares at $0.16 apiece.

NUH to establish health centre for early cancer detection in 2025

The centre will integrate AI and advanced technology into its services.

MOH finds 5,300 more ‘non-viable’ cord blood units at Cordlife

One tank experienced a temperature excursion due to delayed replenishment of liquid nitrogen.

Thomson Medical restores public float to 10.15%

It sold 50 million shares to meet the minimum public float requirement.

Cordlife tackles all but one of TransGlobal's proposed resolution

The company said “Shally Chen” was not listed as its director.

Singapore healthtech faces funding shortfall despite deal surge

The deal value of healthtech deals in 2023 was US$409m.

Red Crowns Senior Living faces fines for Employment Act violations

The MOM found "illegal employment practices" in the firm's previous operating model.

Cordlife halts trading pending announcement

The trading halt took immediate effect.

Auristone bags $5.4m in Elev8.vc-led funding round

The startup will use the capital to promote its flagship product.

Cordlife Group receives third requisition notice from TransGlobal

The board says it will review the request and provide updates as necessary.

StarHub unveils LifeHub+ platform

This will provide consumers access to health and wellness services.

Singapore Food Agency proposes updated guidelines on infant nutrition

Such amendments may result in heightened compliance demands and additional costs for businesses.

Cordlife Group Limited approves potential acquisition by NJXJK

NJXJK is currently reviewing its stake at Cordlife Group with SAC Capital.